FLGT Q3 2022 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q3 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$106M-53.6% YoY

Gross Profit

$46M43.6% margin

Operating Income

$352,0000.3% margin

Net Income

$2M1.6% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

-15.7%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$15M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$124M

Stockholders' Equity

$1.3B

Cash & Equivalents

$169M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$106M	$228M	-53.6%
Gross Profit	$46M	$184M	-75.0%
Operating Income	$352,000	$159M	-99.8%
Net Income	$2M	$123M	-98.6%

Geographic Segments

UNITED STATES

$102M96%

Non-US

$4M4%